Foresite Capital Opportunity Management V, LLC
CIK 0001792207
10% Owner
Filings
15
Latest Apr 3, 2026
Issuers covered
5
Showing
15 of 15
Page 1
Track record
12 of 19 open-market trades scored (63% price coverage) - 7 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 12 | 58% | +34.1% | +43.7% | +89.8% | -28.3% |
| 90 days | 12 | 58% | +137.0% | +24.9% | +376.8% | -33.5% |
| 180 days | 9 | 78% | +126.7% | +201.9% | +279.4% | -40.0% |
| 365 days | 4 | 50% | +196.1% | +187.1% | +486.2% | -75.9% |
Issuers
Companies where Foresite Capital Opportunity Management V, LLC has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ALMS | Alumis Inc. | 6 | Apr 3, 2026 |
| KNTE | Kinnate Biopharma Inc. | 3 | Apr 5, 2024 |
| PRDS | Pardes Biosciences, Inc. | 3 | Aug 31, 2023 |
| THRX | Theseus Pharmaceuticals, Inc. | 2 | Jul 19, 2023 |
| EIKN | Eikon Therapeutics, Inc. | 1 | Feb 6, 2026 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|